Search bioRxiv⌕ Search

Biology subjects

Mizushima, T.

Publications and source records attributed to Mizushima, T..

2 recordsLinked to original sources

Paradoxical tumor suppressive role of the musculoaponeurotic fibrosarcoma gene in colorectal cancer

Somatic cell reprogramming using the microRNAs miR200c, miR-302s, and miR-369s leads to increased expression of cyclin-dependent kinase inhibitors in human colorectal cancer (CRC) cells and suppressed tumor growth. Here, we investigated whether these microRNAs inhibit colorectal tumorigenesis in CPC;Apc mice, which are prone to colon and rectal polyps. Repeated administration of microRNAs inhibited polyp formation. Microarray analysis indicated that c-MAF, which reportedly shows oncogene-like behavior in multiple myeloma and T-cell lymphoma, decreased in tumor samples but increased in microRNA-treated normal mucosa. Immunohistochemistry identified downregulation of c-MAF as an early tumorigenesis event in CRC, with low c-MAF expression associated with poor prognosis. Of note, c-MAF expression and p53 protein levels were inversely correlated in CRC samples. c-MAF knockout led to enhanced tumor formation in azoxymethane/dextran sodium sulfate-treated mice, with activation of cancer-promoting genes. c-MAF may play a tumor-suppressive role in CRC development.

molecular biology↗

Active site structure of the Shigella flexneri effector OspI

Ubc13 is a critical ubiquitin-conjugating enzyme involved in the nuclear factor-{kappa}B (NF-{kappa}B) signalling pathway. The Shigella flexneri effector OspI targets the host Ubc13 and modifies this enzyme by deamidation of Gln100 into Glu100. This modification inhibits the tumour necrosis factor (TNF) receptor-associated factor 6 (TRAF6)-catalyzed ubiquitination and diacylglycerol-CBM (CARD-Bcl10- Malt1)-TRAF6-NF-{kappa}B signal activation. We have previously reported the wild-type OspI crystal structure, but the catalytic triad does not form the canonical active site. Here, the crystal structure of OspI with a C62S mutation was determined at a resolution of 2.2 [A]. This C62S mutant structure provided the active site conformation with the catalytic site of OspI.

biochemistry↗